Form 4: Iradimed Corp Executive Receives Restricted Stock Units

Hilda Frederique Scharen-Guivel, an executive at Iradimed Corp, received restricted stock units that will vest in two equal annual installments starting December 7, 2024.

Summary

• On December 7, 2023, Hilda Frederique Scharen-Guivel received restricted stock units under Iradimed Corporation's 2023 Equity Incentive Plan.
• The restricted stock units will vest in two equal annual installments, beginning on December 7, 2024.
• Upon vesting, the reporting person will receive a number of shares of common stock equal to the number of restricted stock units that have vested.
• The restricted stock units convert into common stock on a one-for-one basis.

Sentiment

Score: 7

Explanation: The document describes a routine executive compensation event, which is generally positive for aligning interests but not a major market-moving event.

Positives

• The grant of restricted stock units aligns the executive's interests with those of the shareholders.
• The vesting schedule encourages long-term commitment from the executive.

Future Outlook

The executive will receive shares of common stock upon vesting of the restricted stock units.

Industry Context

The granting of restricted stock units is a common practice in corporate compensation to incentivize executives and align their interests with shareholders.

Comparison to Industry Standards

• Many companies in the medical device industry use restricted stock units as part of their executive compensation packages.
• The two-year vesting schedule is a fairly standard practice for such grants.

Stakeholder Impact

• Shareholders may view this as a positive sign of aligning executive interests with company performance.
• The executive is incentivized to contribute to the company's long-term success.

Next Steps

• The restricted stock units will vest in two equal annual installments beginning on December 7, 2024.

Key Dates

Keywords

Restricted Stock Units, Equity Incentive Plan, Stock Compensation, Vesting, Iradimed Corp, Executive Compensation